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Abstract
Background: Near-tetraploid (model #81-103) and near-triploid (model #67-81) karyotypes are found in around 1%
of childhood acute lymphoblastic leukemia. Due to its rarity, these two cytogenetic subgroups are generally
included in the hyperdiploid group (model # > 51). Therefore separate informations about these two subgroups
are limited to a few reports. Some studies found that near-tetraploidy is relatively more frequent in higher median
ages and it is associated to Frech-American-British Classification subtype L2. Although the mechanisms by which
leukemic blast cells divide is still unclear, studies have suggested that hyperdiploidy, near-triploidy and near-
tetraploidy do not seem to share the same mechanism.
Findings: Herewith, we present a new childhood T-acute lymphoblastic leukemia case of near-tetraploid karyotype
with loss of two p53-gene copies, characterized in detail by cytogenetic and molecular studies.
Conclusion: We suggest that p53 is a good target gene to be screened, once p53 is one of the main effectors of
cell cycle checkpoints.
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I. Background
Chromosomal ploidy status has well known prognostic
significance implications in childhood acute lymphoblas-
tic leukemia (ALL). In general, model numbers (mn) of
more than 50 chromosomes, are a good prognostic fac-
tor. Among these, high-hyperdiploidy (mn 51-65) is
connected with an excellent outcome. Cases with mn >
65 are rare: near-triploidy (mn 67-81) and near-tetra-
ploidy (NT) (mn 81-103) can be found in only 0.3% and
0.7-2% of childhood ALL, respectively [1,2]. According
to literature, near-tetraploidy appears to be associated to
French-American-British (FAB) Classification L2 cyto-
morphology, and patients with karyotypes of this rare
cytogenetic subgroups usually present in higher median
ages [3].
The immunophenotypic profile comprises both B- and
T- cell lines. While, NT in B-cells is correlated to a
favorable prognosis, NT in T-cells is discussed contro-
versially in the literature. Pui et al. (1990) [3] related
NT in T-cell lineage with a poor prognosis, as 9/20 T-
ALL cases with NT karyotype, 5 of them relapsed or
died despite of the intense chemotherapy. On the other
hand, Lemez et al. (2010) [2] described a favorable out-
come in 36 T-ALL patients.
At cytogenetic level, it is not rare to find structural
abnormalities besides the polyploidy, but the frequent
fuzzy chromosomal appearance and limitations of stan-
dard banding techniques lead to many non-identified
chromosomes hampering a detailed cytogenetic analysis
[1,2]. In the majority of childhood ALL studies, cases of
near-tri- and near-tetraploidy are included in the hyperdi-
ploid group (mn > 51); therefore separate information
about these two subgroups are limited to a few reports [1].
It has been described that, p53 gene may lead the cell
to apoptosis and cellular senescence [4,5]. Some studies
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DNA fail to properly respond to this damage check-
points but instead continue to proliferate, which results
in structural abnormalities, aneuploidy and polyploidy
including tetraploidy. The p53 gene plays an important
role at various checkpoints of the cell cycle, especially in
M-phase, where this gene contributes to the control of
centrosome duplication, and also to the prevention of
DNA duplication when chromosome segregation is
impaired by spindle inhibitors [5].
Herewith we present a new T-ALL child case of NT
karyotype with loss of two p53-gene copies, character-
ized in detail by cytogenetic and molecular studies.
II. Case Presentation
1. Case Report
A 15-year-old male was admitted to the Onco-hematol-
ogy Pediatric Service of The National Cancer Institute
(INCA), Rio de Janeiro, Brazil, on January/2011, present-
i n gc l i n i c a lh i s t o r yo fr e l a t e dd i f f u s eb o n ep a i n ,n i g h t
sweats, leukocytosis, thrombocytopenia and presence of
cells with blastic features.
Physical examination revealed that the patient was
flushed, jaundiced, with active bleeding gums, petechiae
on the palate. It was observed that the presence of
enlarged palpable lymph nodes in the cervical, subman-
dibular, bilaterally axillary and inguinal regions; cardio-
vascular and respiratory systems were normal. The
patient presented hepatomegaly (3 cm below the right
costal margin) and splenomegaly (7 cm below the left
costal margin). His mother was diagnosed as HIV-posi-
tive, as was the patient himself. A diagnostic lumbar
puncture was performed after cranial tomography scans
and showed no signs of bleeding or masses in the
parenchyma.
Laboratory examinations revealed tumor lysis syn-
drome, thrombocytopenia, hypercellularity, and liquor
findings that were consistent with central neural system
(CNS) infiltration. Hemoglobin levels were low (11 g/dl),
white blood cell (WBC) count was 49 × 10
9/l with 58%
blast cells, platelet count was 41 × 10
9/l and LDH was
8580 U/l. The morphological evaluation of bone marrow
contests showed moderate hypercellularity, presence of
lumps and 90% of blast cells with lymphoid characteris-
tics. Flow cytometry revealed a population of blast cells
that expressed CD4/8, CD10, CD7, CD2, TDT, TDT/
cCD3, which was compatible with T-ALL [6]. Molecular
genetic analysis by Reverse Transcriptase Polymerase
Chain Reaction (RT-PCR) excluded the presence of
ETV6/RUNX1 fusion gene [7].
The patient was treated according to medium risk of
BFM 1995 protocol. Peripheral blood of chemotherapy
showed good response to treatment at 8
th day (D) and
bone marrow of D33 showed remission (bone marrow
M1). To date, the patient is enrolled on the mainte-
nance phase of chemotherapy.
2. Banding Cytogenetics
Standard cytogenetic analysis of the bone marrow was
performed. The diagnosis of leukemia was established
based on the French-American-British classification
(FAB) criteria, including clinical manifestations, immu-
nophenotyping and cytogenetic analysis. Karyotypes
were obtained at the time of the case’s diagnosis. GTG-
banding was done according to standard protocols.
Chromosomes were identified and analyzed in accor-
dance with ISCN 2009 [8].
3. Molecular Cytogenetics
The NT karyotype was further analyzed by multiplex
fluorescence in situ hybridization (M-FISH) [9] using all
24 human whole chromosome paints as probes [10].
Additionally, two commercially available probes, centro-
mere specific probe for chromosome 17 (CEP 17) and a
locus specific identifier probe for the p53-gene (LSI
P53) in 17p13.1 (Abbott/Vysis, Place and name of the
probe provider company) were used according to manu-
facturer’s instructions.
III. Results
GTG-banding studies at the time of ALL diagnosis
revealed a NT karyotype (mn 94), including derivative
chromosomes in 15/15 cells (Figure 1A). Since the iden-
tification of some chromosomes and molecular abnorm-
alities were not conclusive, molecular cytogenetics M-
FISH was applied to further validate the data (Figure
1C). The later, identified derivative chromosomes 17,
presenting the loss of two copies of p53 gene, which
were further characterized using cep 17 and LSI p53
(Figure 1D).
Overall, the NT karyotype was characterized as 94,
XXYY, i(17)(q10)x2,+20,+20.
Furthermore, molecular genetics using RT-PCR
excluded the presence of ETV6-RUNX1 fusion gene
(Figure 1B).
IV. Discussion
Although the mechanisms by which leukemic blast cells
divide is still unclear some studies have suggested that
hyperdiploidy, near-triploidy and near-tetraploidy do not
seem to share the same mechanisms. Hyperdiploid leu-
kemic cells generally arise by a simultaneous gain of all
additional chromosomes during a single abnormal cell
division [7]. Some findings using multicolor banding
FISH suggested that near-triploid cases are more likely
to arise by random nondisjunction mechanism [11].
Some studies propose that NT is most likely to be a
doubling of a near-(pseudo)diploid clone with
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neous acquisition of chromosomes, as seen in high-
hyperdiploidy [7].
Abnormal cells, defective checkpoints or cell cycle
regulators, as p53 gene, are thought to be responsible to
the lack for normal division [5]. Near-tetraploidy
observed in our patient is being described in the litera-
ture for the first time as it was ETV6/RUNX1 negative
and presented a loss of 2 copies of p53gene. These find-
ings corroborate to the mechanisms involved in the for-
mation of this karyotype group that could include genes
enrolled in checkpoints. The p53 is one of the main
effectors of cell cycle checkpoints, contributing to the
qualitative and quantitative maintenance of chromoso-
mal stability of the genetic material. Therefore, we sug-
gest that p53 is a good target gene to be screened for
further prospective and retrospective studies in child-
hood near-tetraploid ALL.
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Figure 1 Cytogenetic and molecular analysis. A Partial and total G-banding karyotype showing a near-tetraploidy (mn 94); B RT-PCR results
showing ETV6-RUNX1 fusion gene negative. cDNA of a health donor (DONOR) was used as negative (12;21) control for ETV6-RUNX1 fusion C M-
FISH showing the karyotype: 94, XXYY, i(17)(q10)x2,+20,+20; D FISH cep 17 and LSI p53 showing the deletion of 2 copies of P53 gene on
derivatives i(17q).
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